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IMMUNOLOGIST CONDUCTS 
RESEARCH ON TUBERCULOSIS 
AND RESISTANCE TO INFLUENZA
By Rebecca Yates 
UM Information Services
MISSOULA--
The ironies of "progress" have become increasingly apparent as man wakes up to his 
deteriorating environment. It seems man has made similar "ecological" mistakes in pre­
ventive medicine: in eradicating one disease, he has drastically lowered resistance to 
others.
Such is the theory of Dr. Carl L. Larson, M.D., professor of microbiology at the 
University of Montana, Missoula.
Dr. Larson has been involved with medical checks and balances for many years, ever 
since he read Rachel Carson’s "Silent Spring." As director of the Stella Duncan Memorial 
Institute, founded at UM for the study of allergic diseases, he is presently engaged in 
research on how tuberculosis may actually provide resistance to other diseases.
The Stella Duncan staff previously conducted research which shows that live tubercle 
bacilli provide resistance to fibromatosis, a disease in rabbits characterized by numer
ous benign tumors.
Recently, through a $1,000 grant from the Missoula Cancer Society, Dr. Larson and 
his associates have been making preliminary experiments which they hope will lead
to data supporting Dr. Larson's theory that tuberculosis also provides resistance to
influenza.
In addition, through his experiments with mice, Dr. Larson has tentatively conclu­
ded that the immunity to influenza and related diseases is a cellular one.
In his preliminary research of "Nonspecific Resistance Engendered by Mycobacteria,"
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Dr. Larson has infected a number of mice with Pasteurel1 a novicida, an aquatic 
organism which brings death to mice within seven days.
He has found that mice vaccinated with BCG, a vaccine named after French scientist 
Albert Calmette and surgeon Alphonse Guerin which introduces an active tubercle bacillus 
into the body, show remarkable resistance to the disease produced by P_. novicida.
Compared with the control mice, all of which die within a week, after two weeks, of 
the mice vaccinated with BCG and then infected with P. novicida, only one or two out of 
10 succumb to the usually fatal disease. Also, the number of P. novicida. in the spleens
of the vaccinated mice is impressively decreased.
Dr. Larson is now applying for a federal grant to continue this research and extend 
it into the area of influenza, a disease which he feels reasonably certain can also be 
resisted by small doses of the live BCG vaccine.
He is also interested not only in whether tuberculosis provides immunity to influ­
enza, but whether that immunity is produced by antibodies or is cellular. From his pre­
liminary research he has concluded that "we are dealing with cellular immunity."
In studying resistance to P. novicida he has found that the macrophage cells, the 
"scavenger cells" of the body that "chomp up things," as he put it, are absolutely neces­
sary for resistance.
He has come to this conclusion by injecting
/'"'.--silica
--macrophage
silica into both the control and BCG mice. BCG
mice treated with silica, he found, were no more
N  \
Macrophage begins to 
develop pocket to 
encompass silica.resistant to P. novicida than normal mice, indi­ ^  \ )
eating that macrophages are the "effector" cells
active in resistance.
The scavenger cells, he explained, develop 
a pocket around the introduced silica. Enzymes 
then enter and because of the rough edges of the
more
IMMUNOLOGIST— 3—
silica the pocket is ruptured. Eventually these enzymes leak out and kill the cell and 
subsequently the mouse.
In addition, Dr. Larson has transplanted spleen cells from BCG vaccinated mice into 
the spleens of the control mice and found that the normal mice then become more resistant 
to P_. novicida, although less so than the BCG nice. About 50 per cent of the normal 
mice with the transplanted spleen cells survive.
The concept of cellular immunity is an old one, Dr. Larson indicated, but has 
not been applied as often as might be necessary. For example, he said, the antibodies 
for typhoid may actually be worthless, since it appears that typhoid, like tuberculosis, 
has a basis for resistance in cellular immunity.
He added, however, that whether or not immunity to a disease is produced by cells 
or antibodies varies with different diseases. "It has to be a give and take relation­
ship" among researchers, he said.
Dr. Larson is applying for a five year federal grant of $100,284 to continue his 
research in establishing the basis for nonspecific resistance to infections with P. 
novicida and then to apply those findings to experiments on influenza virus.
In addition, he and his associates are working to isolate the exact antigen, or 
antibody producing agent, in the cell walls of the tubercle bacillus which will provide 
the most effective diagnosis in skin tests for TB.
The skin test now used, lie explained, is not accurate since the substance, PPD 
(purified protein derivative), actually contains 18 different antigens. Thus a person 
showing a positive reaction to the test actually may be infected with organisms other
t
than the tubercle bacillus.
The work of the Institute is carried on with the interest from a bequest left by UM 
alumna Stella Duncan Johnstone, who died in 1948 of bronchial asthma, plus continuing 
grants from the Department of Health, Education,and Welfare.
In -addition, Dr. Larson is one of only 35 persons in this country who holds a
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National Institutes of Health (NIH) Career Research Award for his salary to do research
on resistance to tuberculosis and related disease.
Dr. Larson was bom in Butte, Montana in 1909. He received his medical degree from 
the University of Minnesota in 1939 and holds an honorary doctor of science degree from 
the University of Montana.
He began his career with the NIH in 1939 as assistant chief of the Laboratory of 
Infectious Diseases at Bethesda, Md., and directed the Rocky Mountain Laboratory, Hamil­
ton, from January 1950 to October 1961. He became director of the Stella Duncan Memorial
Institute in October 1962.
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